First Republic Investment Management, Inc. Vericel Corp Transaction History

First Republic Investment Management, Inc.

  • $34.7 Billion
  • Q3 2023

A detailed history of First Republic Investment Management, Inc. transactions in Vericel Corp stock. As of the latest transaction made, First Republic Investment Management, Inc. holds 7,014 shares of VCEL stock, worth $396,010. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,014
Previous 8,963 21.74%
Holding current value
$396,010
Previous $336,000 30.06%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 07, 2023
SELL
$31.69 - $39.25 $61,763 - $76,498
-1,949 Reduced 21.74%
7,014 $235,000
Q2 2023

Jul 28, 2023
SELL
$29.0 - $38.37 $8,236 - $10,897
-284 Reduced 3.07%
8,963 $336,000
Q1 2023

May 11, 2023
SELL
$23.85 - $31.34 $210,667 - $276,826
-8,833 Reduced 48.86%
9,247 $271,000
Q4 2022

Feb 13, 2023
SELL
$17.65 - $27.37 $109,129 - $169,228
-6,183 Reduced 25.48%
18,080 $476,000
Q3 2022

Nov 03, 2022
BUY
$22.62 - $32.54 $57,160 - $82,228
2,527 Added 11.63%
24,263 $563,000
Q2 2022

Aug 16, 2022
BUY
$22.88 - $39.45 $48,528 - $83,673
2,121 Added 10.81%
21,736 $547,000
Q1 2022

May 16, 2022
SELL
$31.69 - $43.29 $128,693 - $175,800
-4,061 Reduced 17.15%
19,615 $750,000
Q4 2021

Feb 09, 2022
SELL
$35.2 - $52.6 $138,230 - $206,560
-3,927 Reduced 14.23%
23,676 $930,000
Q3 2021

Nov 12, 2021
BUY
$46.35 - $59.75 $37,080 - $47,800
800 Added 2.98%
27,603 $1.35 Million
Q2 2021

Aug 16, 2021
BUY
$47.2 - $67.81 $979,352 - $1.41 Million
20,749 Added 342.73%
26,803 $1.41 Million
Q1 2021

May 14, 2021
BUY
$30.93 - $59.48 $187,250 - $360,091
6,054 New
6,054 $336,000

About Vericel Corp

VCEL Quotes by TradingView
  • Ticker VCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,178,000
  • Market Cap $2.66B
  • Description
  • Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for t...
More about VCEL
Track This Portfolio

Track First Republic Investment Management, Inc. Portfolio

Follow First Republic Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Republic Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on First Republic Investment Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email